Evidence map›Paper›PMID 38434688›Full record

ArticleFrontiers in oncology2024

National expert consensus on home-administered oncologic therapies in Spain.

Eulalia Villegas, María Arruñada, Miguel Ángel Casado, Sonia González, María Estela Moreno-Martínez, María Ángeles Peñuelas, Ana Maria Torres, Yanik Sierra, Miguel Angel Seguí

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Recommendations from the Spanish Society of Medical Oncology to advance the humanization in cancer care.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Observational
  3. Article
  4. Home-based treatment for patients with hematological cancer in Denmark-A national overview.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Hospital at home for oncologic patients: SEOM-SEHAD consensus on clinical practice.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eulalia VillegasDos de Maig Hospital, Barcelona, Spain.
María ArruñadaPharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.
Miguel Ángel CasadoPharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.
Sonia GonzálezInnovation in Clinical Pharmacy Research Group (i-FARMA-Vigo), Vigo, Spain.
María Estela Moreno-MartínezPharmacy Service, de la Sant a Creu i Sant Pau Hospital, Barcelona, Spain.
María Ángeles PeñuelasVall d'Hebron University Hospital, Barcelona, Spain.
Ana Maria TorresDos de Maig Hospital, Barcelona, Spain.
Yanik SierraEisai Farmaceutica SA, Madrid, Spain.
Miguel Angel SeguíParc Taulí Foundation, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis and treatment of cancer impose a significant emotional and psychological burden on patients, families, and caregivers. Patients undergo several interventions in a hospital setting, and the increasing number of patients requiring extended care and follow-up is driving the demand for additional clinical resources to address their needs. Hospital at Home (HaH) teams have introduced home-administered oncologic therapies that represent a new model of patient-centered cancer care. This approach can be integrated with traditional models and offers benefits to both patients and healthcare professionals (HCPs). Home-administered treatment programs have been successfully piloted globally, demonstrated as a preferred option for most patients and a safe alternative that could reduce costs and hospital burden. The document aims to establish the minimum recommendations for the home administration of oncologic therapies (ODAH) based on a national expert agreement. The expert panel comprised seven leading members from diverse Spanish societies and three working areas: clinical and healthcare issues, logistical and administrative issues, and economic, social, and legal issues. The recommendations outlined in this article were obtained after a comprehensive literature review and thorough discussions. This document may serve as a basis for the future development of home-administered oncologic therapy programs in Spain. .

Indexed as

expert recommendationshome administrationoncologyoncology therapiesquality of life

Identifiers

PMID38434688
PMCPMC10905380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.